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Abstract
Background
Typhoid fever remains an important disease in Africa, associated with outbreaks and the
emerging multidrug resistant Salmonella enterica serotype Typhi (Salmonella Typhi) haplo-
type, H58. This study describes the incidence of, and factors associated with mortality due
to, typhoid fever in South Africa, where HIV prevalence is high.
Methods and Findings
Nationwide active laboratory-based surveillance for culture-confirmed typhoid fever was
undertaken from 2003–2013. At selected institutions, additional clinical data from patients
were collected including age, sex, HIV status, disease severity and outcome. HIV preva-
lence among typhoid fever patients was compared to national HIV seroprevalence esti-
mates. The national reference laboratory tested Salmonella Typhi isolates for antimicrobial
susceptibility and haplotype. Unadjusted and adjusted logistic regression analyses were
conducted determining factors associated with typhoid fever mortality. We identified 855
typhoid fever cases: annual incidence ranged from 0.11 to 0.39 per 100,000 population.
Additional clinical data were available for 369 (46.8%) cases presenting to the selected
sites. Among typhoid fever patients with known HIV status, 19.3% (29/150) were HIV-
infected. In adult females, HIV prevalence in typhoid fever patients was 43.2% (19/44) ver-
sus 15.7% national HIV seroprevalence (P < .001); in adult males, 16.3% (7/43) versus
12.3% national HIV seroprevalence (P = .2). H58 represented 11.9% (22/185) of Salmo-
nella Typhi isolates tested. Increased mortality was associated with HIV infection (AOR
10.7; 95% CI 2.3–50.3) and disease severity (AOR 9.8; 95% CI 1.6–60.0) on multivariate
analysis.
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Conclusions
Typhoid fever incidence in South Africa was largely unchanged from 2003–2013. Typhoid
fever mortality was associated disease severity. HIV infection may be a contributing factor.
Interventions mandate improved health care access, including to HIV management pro-
grammes as well as patient education. Further studies are necessary to clarify relationships
between HIV infection and typhoid fever in adults.
Introduction
Typhoid fever, infection with Salmonella enterica serotype Typhi (Salmonella Typhi), remains
an important infectious disease in developing countries; the estimated annual disease burden is
10 to 13 million cases [1] with 190 000 deaths globally [2]. Typhoid fever mortality in Africa
has been estimated at 7.2 per 100 000 person-years, double that of south Asia and 25–70 times
that of the rest of the world in a recent systematic review [1]. Typhoid fever appears particu-
larly problematic in emerging economies, with high burdens reported from Kenya [3], Paki-
stan, India and Indonesia [3], where disease is associated with urban informal settlements
[3,4]. Numerous data gaps remain regarding typhoid fever in low and middle income countries
including factors associated with death among typhoid fever patients [5]. The association of
HIV infectionwith typhoid fever also remains unclear: an increased risk of acquiring typhoid
fever among HIV-infected persons was described in Peru [6], whereas a Tanzanian study
found HIV infectionwas associated with a decreased risk of typhoid fever [7]. HIV infection is
a particular public health problem in South Africa where 15% of the population15 years of
age were HIV-infected in 2013 [8].
Recently, a multidrug resistant haplotype of Salmonella Typhi, H58, has emerged in South
East Asia [9–11], and Africa [12,13]. This emergencemay be related to increased virulence or
selective pressures created by antimicrobial use [14]. We report on the incidence of typhoid
fever in South Africa from 2003 to 2013, the clinical and microbiological features of typhoid
fever that may drive mortality, including association with HIV infection and the prevalence of
Salmonella Typhi H58.
Methods
Surveillance
Nationwide active laboratory-based surveillance for culture-confirmed typhoid fever, (isolation
of Salmonella Typhi from a normally sterile site), was performed by the Centre for Enteric Dis-
eases (CED) of the National Institute for Communicable Diseases in South Africa from 2003
through 2013, as previously described [15]. Specifically, we requested that all diagnostic labora-
tories in South Africa send all Salmonella Typhi isolates to CED and performed audits to iden-
tify additional laboratory-confirmedcases of typhoid fever for which Salmonella Typhi isolates
were not received using the Central Data Warehouse (CDW), a national databank derived
from the laboratory information system storing basic demographic and laboratory data for all
typhoid fever cases diagnosed by the National Health Laboratory Service [15] (active case find-
ing). Ethical approval for this study was granted by the Human Research Ethics Committee of
the University of theWitwatersrand (M110601).
At 25 hospitals selected to represent major centres in the nine South African provinces,
additional information was collected frommedical records of typhoid fever patients through
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GERMS-SA, a national surveillancenetwork sharing resources to characterise diseases of pub-
lic health importance in South Africa.Written informed consent from the patient or (care pro-
vider, in the case of minors) was obtained for those patients for whom interviewswere
conducted.Where clinical data was obtained solely from clinical record review, no written
informed consent was obtained from the patient. Patient records could not be anonymised as
patient information was required to cross reference each case with those cases that were noti-
fied through audit of the NHLS CDW, to avoid duplicating case counts. Patient records were
reviewed for clinical presentation, HIV infection and other co-morbidities, and outcome (sur-
vival or death). A patient was considered to have co-morbid disease if they had any of the fol-
lowing diagnoses: tuberculosis,malignancy, autoimmune disease, renal disease, liver failure,
diabetes mellitus, protein energymalnutrition (children) or congested cardiac failure. A Pitt
bacteraemia score (PBS) was determined for patients with typhoid fever by assigning values
between 0 and 2 for presence of fever or hypopyrexia, mechanical ventilation and hypotension
or 0 and 4 for cardiac arrest and mental status. Higher scores correspondedwith increased
severity of illness [15,16].
HIV prevalence among male and female typhoid fever patients15 years of age were com-
pared to national HIV seroprevalence estimates from the 2008 Actuarial Society of South
Africa (ASSA) [8].
Laboratory
All clinical diagnostic laboratories in South Africa were requested to submit Salmonella Typhi
isolates to CED for confirmation and further characterisation in accordance with GERMS-SA
network guidelines. At CED, Salmonella serotype was confirmed according to theWhite-Kauf-
mann-LeMinor scheme and antimicrobial susceptibility to ampicillin, trimethoprim-sulfa-
methoxazole, chloramphenicol, tetracycline, ciprofloxacin and ceftriaxonewas determined
using E-tests, according to the manufacturer’s instructions (BioMérieux,Marcy-l’Étoile,
France). Multidrug resistance (MDR) was defined as resistance to three or more of these
antimicrobials.
The presence of the H58 haplotype was confirmed using conventional PCR [17].
Statistical analysis
Typhoid fever incidence calculations used national population estimates from ASSA [8]. Uni-
variate and multivariate logistic regression were used to determine factors (age, sex, HIV status,
PBS, other comorbidities, multidrug resistance and H58 haplotype) associated with mortality
among typhoid fever patients. Analyses were performedusing Stata version 13 (StataCorp Lim-
ited, College Station, TX, USA). Two-sided P values of< .05 were considered significant
throughout. To assess changes in typhoid fever mortality over time, corresponding to changes
in the proportion of the population of HIV-infected persons with access to antiretroviral treat-
ment [8], we defined early (2003–2005), middle (2006–2010) and late (2011–2013) study peri-
ods. The Fisher Exact test and Chi-squared (in adult women) test were used to compare HIV
prevalence among typhoid fever patients and national seroprevalence estimates.
Results
Surveillance
From 2003 to 2013, we ascertained 855 cases of culture-confirmed typhoid fever in South
Africa: 67 (7.8%) were identified on audit of the CDW: the number of cases annually ranging
from 48 to 187. With the exception of increases in culture-confirmed typhoid cases in 2005
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and 2006, the incidence in South Africa was largely unchanged from 2003 to 2013, ranging
from 0.11 per 100,000 population in 2013 to 0.39 per 100,000 population in 2005 (Table 1).
Age was available for 814 cases, ranging from 0 days (birth) to 81 years with a median of 15
years. Sex was available for 841 cases; 470 (55.9%) were male. Sex and age were available for
803 cases (Fig 1). Among 855 typhoid fever cases, Salmonella Typhi was isolated from blood in
816 (95.4%), CSF in 4 (0.5%) and other body sites in 35 (4.1%) cases.
Laboratory
Isolates were received at CED from 788 (92.2%) of the 855 cases: 760 (96.4%) were viable and
confirmed as Salmonella Typhi. Antimicrobial susceptibility testing on 758 (99.7%) indicated
175 (23.1%) were resistant to ampicillin, 165 (21.8%) to co-trimoxazole, 91 (12.0%) to chlor-
amphenicol, 111 (14.6%) to tetracycline, 69 (9.1%) resistant to ciprofloxacin and 1 (0.1%) to
ceftriaxone (two isolates died before susceptibilities could be confirmed).Multidrug resistance
was recorded in 158 (20.8%). Salmonella Typhi H58 represented 22 (11.9%) of 185 isolates
tested; 14/22 (63.6%) H58 isolates were multidrug resistant compared with 26/163 (16.0%)
non-H58 isolates (P< .001).
Selected sites
Additional clinical data including outcome (recovery or death) were available for 369 (46.8%)
cases presenting to the selected sites. Presence or absence of fever was recorded for 215 (59.1%)
cases; 130 (60.5%) presented with fever (temperature38°C) and 18 (8.4%) were hypopyrexial
(temperature<36.5°C). Of the 196 cases with sufficient clinical information to derive a PBS, 12
(6.1%) had a PBS4; patients with PBS4 reported later to hospital compared with patients
with PBS<4 (data not shown). HIV status at time of typhoid fever diagnosis was recorded for
150 (41.2%) cases; 29 (19.3%) were HIV-infected (Table 2). Record review suggested no differ-
ences in patient management between 29 HIV-infected patients compared with 121 HIV unin-
fected patients. Among 63 persons<15 years of age with recordedHIV status, 3 (4.8%) were
HIV-infected. Among 87 persons 15 years of age with recordedHIV status, 26 (29.9%) were
HIV-infected. The proportion of typhoid fever patients15 years of age who were HIV-
infected at the time of typhoid fever diagnosis was 36.4% (8/22) in 2003–2005, 28.1% (9/32) in
2006–2010, and 27.3% (9/33) in 2011–2013. Among female patients15 years of age with
Table 1. Number of cases and incidence rates per 100,000 population of culture-confirmed typhoid fever cases in South Africa 2003–2013
(N = 855).
Year Number of culture-confirmed typhoid fever cases South African Population* Incidence rate of culture-confirmed typhoid fever cases
2003 60 47150661 0.13
2004 72 47676795 0.15
2005 187 48155945 0.39
2006 114 48605035 0.23
2007 66 49034069 0.13
2008 67 49459134 0.14
2009 58 49905065 0.12
2010 62 50371513 0.12
2011 64 50840589 0.13
2012 48 51304466 0.09
2013 57 51759127 0.11
*Data derived from ASSA tables [8].
doi:10.1371/journal.pone.0164939.t001
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recordedHIV status, 19/44 (43.2%) were HIV-infected at time of typhoid fever diagnosis ver-
sus 7/43 (16.3%) males (p = .009).
According to ASSA estimates from 2003 to 2013, average national HIV seroprevalence in
females15 years of age was 15.7%; female typhoid fever patients15 years of age had a sig-
nificantly higher HIV seroprevalence (19/44; 43.2%) than national estimates for females15
years of age (15.7%) (p< .001). Average national HIV seroprevalence from 2003 to 2013 in
males15 years of age was 12.3%; male typhoid fever patients15 years of age had a higher
HIV seroprevalence (7/43; 16.3%) than national estimates for males15 years of age (12.3%),
although this was not significant (p = .2).
The presence or absence of co-morbidities for typhoid cases was determined frommedical
records available 362 (98.1%) of 369 cases available from these sites; 26 (7.2%) had co-morbidi-
ties including diabetes mellitus, malignancy, protein-energymalnutrition, congestive cardiac
failure and hepatic failure. No patients, including HIV-infected patients, had other bacterial
co-infections. Eight HIV-infected patients refused hospital treatment; further clinical informa-
tion was unavailable from these patients.
Final patient outcome (hospital discharge or death) was available for 237/369 (65.1%) cases
from these sites; 16 (6.8%) died (Table 2). Among the patients who died, sex was known for 15;
7 (46.7%) were male. The ages of these 16 patients ranged from 7 to 65 years, with a median of
19.5 years. Of the 237 cases with final hospital outcome data, Salmonella Typhi was isolated
from blood or CSF in 232 cases; 196 of these had a recorded PBS (median PBS 1; range 0–7), of
whom 12 (6.1%) had a PBS4.
Fig 1. Number of culture-confirmed typhoid fever cases (N = 803) by age range and sex in South Africa, 2003–2013.
doi:10.1371/journal.pone.0164939.g001
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Final hospital outcome data were known for 55 of 158 (34.8%) typhoid fever patients
infected with multidrug resistant Salmonella Typhi; 5 (9.1%) of whom died. Outcome was
known for 19 (90.5%) of the 21 typhoid fever patients infected with H58, of whom one (5.3%)
died.
On unadjusted analysis, age15 years (Odds Ratio [OR] 4.1; 95% Confidence Interval [CI]
1.1–14.9), HIV infection (OR 11.3; 95% CI 3.0–42.4), and PBS4 (OR 10.8; CI 2.9–39.5) were
associated with death among typhoid fever patients (Table 3). On adjusted analysis, HIV infec-
tion (Adjusted OR [AOR] 10.8; 95% CI 2.3–50.3) and PBS4 (AOR 9.8; 95% CI 1.6–60.0)
Table 2. Clinical and laboratory characteristics associated with patients with culture-confirmed
typhoid fever in South Africa (N = 369), 2003–2013, based on data from sentinel sites.
Characteristic Total n (%)
Age 361*
< 2 Months 1 (0.3)
2 Months—< 1 Year 10 (2.8)
1–4 Years 38 (10.5)
5–14 Years 132 (36.6)
15–24 Years 84 (23.3)
25–34 Years 46 (12.7)
35–44 Years 28 (7.8)
45–54 Years 11 (3.0)
55–64 Years 6 (1.6)
> 65 Years 5 (1.4)
Sex 367*
Male 196 (53.4)
Female 171 (46.6)
Outcome 237*
Death 16 (6.8)
Recovery 221 (93.2)
HIV status 150*
Uninfected 121 (80.7)
Infected 29 (19.3)
Antiretroviral access period 369*
Early 2003–2005 141 (38.3)
Mid 2006–2009 140 (37.9)
Late 2010–2013 88 (23.8)
Pitt bacteraemia score (severity of illness) 196*
<4 184 (93.9)
4 12 (6.1)
Other comorbidity 362*
No 336 (92.8)
Yes 26 (7.2)
Multidrug resistance 330*
No 236 (71.5)
Yes 94 (28.5)
Salmonella Typhi haplotype 176*
Non-H58 155 (88.1)
H58 21 (11.9)
*Total excludes those patients for whom results were unknown.
doi:10.1371/journal.pone.0164939.t002
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remained associated with mortality. Neither multidrug resistance nor Salmonella Typhi H58
was associated with mortality among typhoid fever patients (Table 3); there were additionally
no differences betweenHIV-uninfected and HIV-infected individuals in the occurrence of
multidrug resistance Salmonella Typhi or the isolation of Salmonella Typhi H58 (P = 0.5and
P = 0.3, respectively).
Discussion
Typhoid fever remains an important public health challenge in South Africa [18–20]. Incidence
rates of culture-confirmed typhoid fever were between 0.11 and 0.39 per 100,000 population;
peaking in 2005 and 2006, due to typhoid outbreaks of over 600 clinically diagnosed cases, of
which approximately 160 were culture-confirmedand captured in our surveillance [19].
Factors associatedwith mortality among persons with typhoid fever on multivariate analysis
were HIV-infection and disease severity as measured by PBS (Table 3). When we reviewed
individual patient records from the sentinel sites, no differences were identified between the
management of HIV-infected and uninfected patients: i.e. all patients were appropriately and
timeously treated, based on a positive culture result of invasive Salmonella Typhi at the pre-
senting hospital. Independently of HIV status, PBS score was significantly associated with
Table 3. Univariate and multivariate analysis of risk factors associated with mortality in patients with Salmonella Typhi in South Africa, 2003–
2013.
Unadjusted analysis Adjusted analysis
Characteristic OR (95% CI) P AOR (95% CI) P
Age
<15 years 1 - - 1 - -
15 years 4.1 (1.1–14.9) .03 2.0 (0.2–19.3) .6
Sex
Male 1 - -
Female 1.4 (0.5–3.8) .5
HIV status
Uninfected 1 - - 1 - -
Infected 11.3 (3.0–42.4) < .001 10.8 (2.3–50.3) .002
Antiretroviral access period
Early 2003–2005 1 - -
Mid 2006–2009 1.7 (0.6–5.4) .3
Late 2010–2013 0.4 (0.1–2.3) .3
Pitt bacteraemia score
<4 1 - - 1 - -
4 10.8 (2.9–39.5) < .001 9.8 (1.6–60.0) .01
Other co-morbid conditions
No 1 - -
Yes 2.1 (0.5–8.0) .2
Multidrug resistance
No 1 - -
Yes 1.7 (0.6–5.3) .3
Salmonella Typhi haplotype
Non-H58 1 - -
H58 0.7 (0.09–5.8) .8
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio
doi:10.1371/journal.pone.0164939.t003
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mortality. Specifically, in our series, late access to health care appeared critical in contributing
to mortality due to severity of illness in typhoid fever patients, rather than belated diagnosis
and treatment delays in hospital or inappropriate treatment.
Among the clinical records we reviewed, only HIV-infected typhoid fever patients refused
hospital treatment. This, and the observation that typhoid fever patients may delay accessing
health care, suggest patient and population education is paramount in managing typhoid fever
from a public health and an individual patient perspective.
Our finding that 16.3% of adult male patients versus 43.2% of adult females with typhoid
fever were HIV-infected may be related to the antenatal testing programme for HIV status in
pregnant women within the country [21]: most South African women who have borne children
would know their HIV status, which would be recorded on hospital admission, in contrast to
South Africanmen. Sex, moreover, was not significantly associated with mortality. Previously
we observed a female predominance among HIV-infected adults with systemic shigellosis,
which included patients from selected and non-selected sites and was ascribed to the burden of
childcare of children with Shigella diarrhoea [15]. Here, no general female predominance was
observed: 53.4% culture-confirmedcases in sentinel sites were male: the marked HIV predomi-
nance recorded among women in this series may potentially be indicative of testing biases.
HIV infection is also more common in women of child-bearing age than in men [8,21], thus, a
combination of factors, both clinical and due to sampling methods,may have influenced the
numbers of HIV-infected women presenting with typhoid fever, as limited numbers of patients
from the sentinel sites had HIV status determined.
HIV prevalence observed among women and men15 years of age with typhoid fever, was
higher than the comparable national seroprevalence, significantly so in women [8], suggesting
HIV-infected adults may be at greater risk of acquiring typhoid fever. This apparent predomi-
nance contrasts observations by Crump et al [7], who found HIV-infected adolescents and
adults less likely to acquire typhoid fever compared with HIV-uninfected patients. This earlier
study was a clinically-based fever study: only patients with documented fever>38°C were
included. Our study used laboratory-based surveillance enrolling all patients with culture-con-
firmed disease, irrespective of clinical characteristics, including fever. Approximately 40% of
our patients were hypopyrexial or apyrexial on admission, possibly contributing to these
observeddifferences. As the immune response is necessary for the development of fever [22], if
this is defective, it is feasible the classic fever curves associated with typhoid fever may not be
observed.Moreover, functional CD4 cells are necessary to combat typhoid fever in healthy
adults [23] and transient defects in these cells have previously been associated with opportunis-
tic typhoid fever infection [24].
Undefined parameters may nonetheless make women more susceptible to typhoid fever:
Khan et al described a series from Durban, South Africa, in which women were more likely to
have severe disease, although they excluded HIV status in the analysis [25]. Other literature
series examining the association of HIV and typhoid fever have looked at populations where
HIV is predominantly a male disease, in men who have sex with men [6,26], where sexual prac-
tices may constitute an additional risk factor, or the male-to-female ratio for typhoid fever was
not reported [7]. Not all reports from African countries have highlighted a female predomi-
nance [4,27], although increased numbers of women were reported from large outbreaks of
typhoid fever in Zimbabwe [28] and Malawi [29]: HIV status was not documented in these
reports. In Zambia, male-to-female ratios were equal in a large outbreak from 2010 to 2012,
but most cases were reported in children less than 15 years of age [12].
In children, typhoid fever is typically associated with the 5 to 15 year age group in South
Africa [18], in which the HIV prevalence was calculated at 3% in 2003 [8]; in the absence of
ART, few HIV-infected children survive beyond 5 years of age. It is likely in this age group,
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very few HIV-infected children with typhoid fever would have unknownHIV status, given cur-
rent testing recommendations in the country [30]. Most children with typhoid fever in this
series under five years of age would have benefited from the perinatal antiretroviral programme
introduced in 2004 [31], very few HIV-infected children would be expected among this age
group, in which typhoid fever incidence is also low. It is therefore unsurprising that typhoid
fever was not significantly associated with HIV infection in children under 15 years of age.
The presence of multidrug resistant (MDR) Salmonella Typhi H58 in South Africa has pre-
viously been reported [32]. This virulent,MDR clade affected both HIV-infected and unin-
fected patients equally, irrespective of these two groups of patients’ susceptibility to typhoid
fever. This virulent strain appears not to be specifically adapted to a vulnerable population
group, as has been reported with Salmonella Typhimurium ST313 in Africa [33], including an
association with Salmonella meningitis in South Africa [34], but probably emerged as a result
of global population movements and wide-spread use and misuse of antimicrobial therapy
[32].
This study had limitations. Primarily, missing data for certain clinical parameters may have
affected the data analyses and results. Secondly, not all cases of typhoid fever over the study
periodwere included: the majority of cases related to the 2005 typhoid fever outbreak did not
have blood cultures done due to resource constraints [19]. In non-outbreak years, cases may
similarly have beenmissed, thus burden of disease estimates could not be calculated. A lack of
robustness of the data with year-on-year variation in case numbers and incompleteness of the
HIV results meant that imputation of data for patients with unknownHIV status could lead to
biased inference. From 2004, ART was rolled out in South Africa [31]. We attempted to over-
come the data insufficiencies regarding HIV status through analysing the data based on early,
mid and late ART periods, showing no association betweenHIV and typhoid fever in children,
possibly due to decreasingHIV seroprevalence following the introduction of ART [30] and the
preponderance of children aged 5 to 14 years with typhoid fever [18]. Limited numbers of
cases with HIV results and the increased prevalence of HIV infection in adults and in women
in particularmay account for apparent associations betweenHIV-infected women and typhoid
fever. HIV seroprevalence in adults was nonetheless greater than the overall prevalence of
HIV-infected adults in South Africa [8]: the role of HIV as a risk factor for the development of
typhoid fever still needs further exploration.
Conclusions
In summary, typhoid fever in South Africa remains a public health challenge. Persons with
typhoid fever who are HIV-infected or severely ill are more prone to mortality. Disease severity
may be affected by access to health care and treatment delays; multidrug resistance and H58
haplotype were not associated with mortality. Salmonella Typhi H58 has not specifically
emerged in Africa in response to the HIV pandemic, but has probably expanded as a clone in
association with population movements and antimicrobial usage practices on the African con-
tinent. Public health interventions should include patient and population education and
enhancedmanagement of HIV infection, including testing patients with typhoid fever, who
may be at risk for HIV infection, in order that they may benefit from national treatment plans.
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